Form 4 for OM Outset Medical, Inc.
Accepted 2021-12-02 00:00:00 ET · period of report 2021-12-01 · accession 0001484612-21-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-02 | 2021-12-01 | OM | Brottem John L. | GC | M - OptEx | $9.48 | +3,500 | 18.5K | +23% | +$33.2K |
| D | 2021-12-02 | 2021-12-01 | OM | Brottem John L. | GC | S - Sale+OE | $47.92 | -3,500 | 15.0K | -19% | -$167.7K |
| D | 2021-12-02 | 2021-12-01 | OM | Brottem John L. | GC | M - OptEx | $0.00 | -3,500 | 10.3K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-01 | M | A | 3,500 | $9.48 | 18,547 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-01 | S | D | 3,500 | $47.92 | 15,047 | D | — | — | |
| 3 | Derivative | Performance Options (right to buy) | 2021-12-01 | M | D | 3,500 | $0.00 | 10,265 | D | $9.48 · — to 2030-05-26 | 3,500 Common Stock | (F2) This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. |